ACTA1 and metabolic dysfunction-associated steatohepatitis: In addition to the acute CCL4 liver fibrosis model, we also found that liver fibrosis was significantly attenuated after TMAO treatment in the NASH model, as determined by H&E, Sirius red, Masson staining and Western blot of αSMA (Figures 3I–L).